A systematic framework for identifying prognostic necroptosis-related lncRNAs and verification of lncRNA CRNDE/miR-23b-3p/IDH1 regulatory axis in glioma

por Chen, Yangxia, Hu, Di, Wang, Fang, Huang, Cheng, Xie, Hesong, Jin, Ling
Publicado 2023

Urinary Metabonomic Profiling Discriminates Between Children with Autism and Their Healthy Siblings

por Liang, Yujie, Xiao, Zhou, Ke, Xiaoyin, Yao, Paul, Chen, Yangxia, Lin, Ling, Lu, Jianping
Publicado 2020

Effect and safety of acupuncture for autism spectrum disorders: A protocol for systematic review and meta-analysis

por Zhang, Ying, Zeng, Jianfei, Wu, Dan, Li, Xiujuan, Chen, Yangxia, Dai, Shixia, Wang, Bing, Qi, Yu, Lu, Jianping
Publicado 2021

Untargeted Metabolomic Profiling Using UHPLC-QTOF/MS Reveals Metabolic Alterations Associated with Autism

por Liang, Yujie, Ke, Xiaoyin, Xiao, Zhou, Zhang, Ying, Chen, Yangxia, Li, Yingyuan, Wang, Zhonglei, Lin, Ling, Yao, Paul, Lu, Jianping
Publicado 2020

Molecular Characteristics of Regional Chromoblastomycosis in Guangdong, China: Epidemiological, Clinical, Antifungal Susceptibility, and Serum Cytokine Profiles of 45 Cases

por Liu, Hongfang, Sun, Jiufeng, Li, Minying, Cai, Wenying, Chen, Yangxia, Liu, Yinghui, Huang, Huan, Xie, Zhenmou, Zeng, Weiying, Xi, Liyan
Publicado 2022

JAK1/2 Inhibitor Baricitinib Improves Skin Fibrosis and Digital Ulcers in Systemic Sclerosis

por Hou, Zhanying, Su, Xuehan, Han, Guangming, Xue, Ruzeng, Chen, Yangxia, Chen, Ye, Wang, Huan, Yang, Bin, Liang, Yunsheng, Ji, Suyun
Publicado 2022

Corrigendum: JAK1/2 inhibitor baricitinib improves skin fibrosis and digital ulcers in systemic sclerosis

por Hou, Zhanying, Su, Xuehan, Han, Guangming, Xue, Ruzeng, Chen, Yangxia, Chen, Ye, Wang, Huan, Yang, Bin, Liang, Yunsheng, Ji, Suyun
Publicado 2023